Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Psychedelic Experiences: early-phase trial registry
3 of 5 indexed Psychedelic Experiences trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Psychedelic Experiences: 5 US clinical trials tracked, 3 recruiting.
Psychedelic Experiences is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is University of Wisconsin, Madison, running 2 of these trials.
Enrollment posture brief
Registry condition psychedelic-experiences
OPEN 3 | RECR 60% | LATE 0 | EARLY 4 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)
Psychedelic Experiences lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Psychedelic Experiences on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Psychedelic Experiences is recruiting above its size-band peers.
3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Psychedelic Experiences research.
University of Wisconsin, Madison accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.
-
Most Psychedelic Experiences trials plan to enrol fewer than 100 people.
Median target enrolment is 15 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.
-
Psychedelic Experiences research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
The ENHANCE Study: taVNS and Psilocybin
University of Wisconsin, Madison
NCT05866471
Safety for Home Administration of Microdose Psilocybin Use
Johns Hopkins University
NCT06450210
Psychedelic Virtual Reality
Yale University
NCT06581263
Neural and Physiological Correlates of Psychedelic Sub-states
Robin Carhart-Harris, PhD, MA
NCT05698511
Pilot RECAP Study in Healthy Volunteers
University of Wisconsin, Madison
NCT04842045
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Psychedelic Experiences records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Psychedelic Experiences trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Psychedelic Experiences page
5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Psychedelic Experiences trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Wisconsin, Madison sponsors the most Psychedelic Experiences trials on record, review their full trial history before evaluating a specific study. See University of Wisconsin, Madison's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Psychedelic Experiences condition card totals 5 registered trials; most-linked intervention Psilocybin; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.